Efficacy and Safety of Optic Nerve Sheath Fenestration for Idiopathic Intracranial Hypertension: A Subgroup-Focused Systematic Review and Meta-Analysis
ASIDE IM issue 3
PDF
Supplementary File

Keywords

Idiopathic Intracranial Hypertension
Optic Nerve Sheath Fenestration
Meta-Analysis
Systematic Review
Visual Outcomes
Benign Intracranial Hypertension

Categories

How to Cite

1.
Almasoud F, Alabduljabbar A, Alotaibi A, et al. Efficacy and Safety of Optic Nerve Sheath Fenestration for Idiopathic Intracranial Hypertension: A Subgroup-Focused Systematic Review and Meta-Analysis. ASIDE Int Med. 2025;1(3):7-13. doi:10.71079/ASIDE.IM.1542545

Funding data

Abstract

Introduction: Optic nerve sheath fenestration (ONSF) is an important surgical management option for idiopathic intracranial hypertension (IIH) who failed medical treatment. We conducted a systematic review and meta-analysis to evaluate the outcomes of ONSF, with a focus to identify factors affecting treatment success.

Methods: A literature search was conducted up to December 2024. Primary outcomes included improvement in visual acuity, visual fields, and optic disc swelling resolution. We performed a detailed subgroup analysis based on geographic location, study design, surgical approach, and technical variations.

Results: Nineteen studies with a total of 1,159 patients were included in our study. ONSF significantly improved visual acuity in 34.5% (95% CI: 31.8-37.3%) and visual fields in 69.4% (95% CI: 65.9-72.7%) of cases. A 90.9% improvement rate was observed in reducing optic disc swelling. Significant heterogeneity was noted in visual acuity (I²=92.1%) and visual field improvements (I²=73.8%). The overall complication rate was 9% (95% CI: 5-16%). Centers that included 30 or more patients in their study demonstrated significantly lower postoperative complications.

Conclusions: ONSF demonstrates favorable efficacy in improving visual outcomes with an acceptable safety profile, lower postoperative complications were observed when the procedure was performed in high-volume centers using appropriate surgical techniques. Geographic variations and surgical approaches significantly affected outcomes, highlighting the importance of standardized protocols and adequate surgical experience. Future prospective studies with standardized outcome measures are needed to optimize patient selection and surgical techniques.

PDF
Supplementary File

References

1. Colman BD, Boonstra F, Nguyen MN, Raviskanthan S, Sumithran P, White O, Hutton EJ, Fielding J, van der Walt A. Understanding the pathophysiology of idiopathic intracranial hypertension (IIH): a review of recent developments. Journal of neurology, neurosurgery, and psychiatry. 2024: 375 [PMID: 37798095, https://doi.org/10.1136/jnnp-2023-332222]

2. Shah S, Khan A, Khan M, Lakshmanan R. Paediatric idiopathic intracranial hypertension: Epidemiology, clinical features and treatment outcomes in a tertiary care centre in Western Australia. Journal of paediatrics and child health. 2024: 499 [PMID: 39014968, https://doi.org/10.1111/jpc.16622]

3. Bsteh G, Macher S, Krajnc N, Marik W, Michl M, Muller N, Zaic S, Harreiter J, Novak K, Wober C, Pemp B. An interdisciplinary integrated specialized one-stop outpatient clinic for idiopathic intracranial hypertension-a comprehensive assessment of clinical outcome. European journal of neurology. 2024: e16401 [PMID: 39152571, https://doi.org/10.1111/ene.16401]

4. Mollan SP, Davies B, Silver NC, Shaw S, Mallucci CL, Wakerley BR, Krishnan A, Chavda SV, Ramalingam S, Edwards J, Hemmings K, Williamson M, Burdon MA, Hassan-Smith G, Digre K, Liu GT, Jensen RH, Sinclair AJ. Idiopathic intracranial hypertension: consensus guidelines on management. Journal of neurology, neurosurgery, and psychiatry. 2018: 1088 [PMID: 29903905, https://doi.org/10.1136/jnnp-2017-317440]

5. Kalyvas A, Neromyliotis E, Koutsarnakis C, Komaitis S, Drosos E, Skandalakis GP, Pantazi M, Gobin YP, Stranjalis G, Patsalides A. A systematic review of surgical treatments of idiopathic intracranial hypertension (IIH). Neurosurgical review. 2021: 773 [PMID: 32335853, https://doi.org/10.1007/s10143-020-01288-1]

6. Bouthour W, Bruce BB, Newman NJ, Biousse V. Factors associated with vision loss in idiopathic intracranial hypertension patients with severe papilledema. Eye (London, England). 2025: 185 [PMID: 39478195, https://doi.org/10.1038/s41433-024-03408-3]

7. El-Masri S, Wilson M, Goh J, Sanfilippo P, Fok A, Hardy T, Chakrabarti R, Van Der Walt A. A 20-year multicentre retrospective review of optic nerve sheath fenestration outcomes. Therapeutic advances in neurological disorders. 2023: 17562864231197994 [PMID: 37719666, https://doi.org/10.1177/17562864231197994]

8. Kalyvas AV, Hughes M, Koutsarnakis C, Moris D, Liakos F, Sakas DE, Stranjalis G, Fouyas I. Efficacy, complications and cost of surgical interventions for idiopathic intracranial hypertension: a systematic review of the literature. Acta neurochirurgica. 2017: 33 [PMID: 27830325, https://doi.org/10.1007/s00701-016-3010-2]

9. Spitze A, Lam P, Al-Zubidi N, Yalamanchili S, Lee AG. Controversies: Optic nerve sheath fenestration versus shunt placement for the treatment of idiopathic intracranial hypertension. Indian journal of ophthalmology. 2014: 1015 [PMID: 25449938, https://doi.org/10.4103/0301-4738.146012]

10. Sachdeva V, Singh G, Yadav GJN-oD. Recent Advances in the Management of Idiopathic Intracranial Hypertension (IIH)2020: 17 https://doi.org/10.1007/978-981-13-8522-3_2]

11. Subramanian PS. Novel Approaches to the Treatment of Idiopathic Intracranial Hypertension. Current neurology and neuroscience reports. 2024: 265 [PMID: 38864967, https://doi.org/10.1007/s11910-024-01347-w]

12. Azzam AY, Mortezaei A, Morsy MM, Essibayi MA, Ghozy S, Elamin O, Azab MA, Elswedy A, Altschul D, Kadirvel R, Brinjikji W, Kallmes DF. Venous sinus stenting for idiopathic intracranial hypertension: An updated Meta-analysis. Journal of the neurological sciences. 2024: 122948 [PMID: 38457956, https://doi.org/10.1016/j.jns.2024.122948]

13. Mollan SP, Grech O, Alimajstorovic Z, Wakerley BR, Sinclair AJ. New horizons for idiopathic intracranial hypertension: advances and challenges. British medical bulletin. 2020: 118 [PMID: 33200788, https://doi.org/10.1093/bmb/ldaa034]

14. McCluskey PJ, Lam D, Ang T, Todd MJ, Halmagyi GM. Optic nerve sheath fenestration for treating papilloedema in the era of cerebral venous sinus stenting. Clin Exp Ophthalmol. 2023: 349 [PMID: 36754636, https://doi.org/10.1111/ceo.14212]

15. Gupta L, Vora P, Benningfield M, Altman EA, Sudhakar P, Timoney PJ. Optic Nerve Sheath Fenestration: A Retrospective Review of Its Safety, Efficacy, and Impact on Optical Coherence Tomography. Ophthalmic Plast Reconstr Surg. 2025: 213 [PMID: 39378203, https://doi.org/10.1097/IOP.0000000000002792]

16. Ghaffari-Rafi A, Mehdizadeh R, Ko AWK, Ghaffari-Rafi S, Leon-Rojas J. Idiopathic Intracranial Hypertension in the United States: Demographic and Socioeconomic Disparities. Frontiers in neurology. 2020: 869 [PMID: 33013623, https://doi.org/10.3389/fneur.2020.00869]

17. McCluskey G, Doherty-Allan R, McCarron P, Loftus AM, McCarron LV, Mulholland D, McVerry F, McCarron MO. Meta-analysis and systematic review of population-based epidemiological studies in idiopathic intracranial hypertension. European journal of neurology. 2018: 1218 [PMID: 29953685, https://doi.org/10.1111/ene.13739]

18. Soylev Bajin M, Durmaz Engin C, Yaman A, Ayhan Z, Gokcay F, Celebisoy N, Men S, Akdal G, Halmagyi GM. Optic nerve sheath decompression saves sight in severe papilloedema: results from 81 eyes in 56 patients with pseudotumor cerebri. Acta ophthalmologica. 2021: e991 [PMID: 33377617, https://doi.org/10.1111/aos.14732]

19. Goksu E, Bozkurt B, Ilhan D, Ozak A, Cirak M, Yagmurlu K. Endoscopic Bilateral Optic Nerve Decompression for Treatment of Idiopathic Intracranial Hypertension. Brain sciences. 2021: [PMID: 33806665, https://doi.org/10.3390/brainsci11030324]

20. Jefferis JM, Littlewood RA, Pepper IM, Hickman SJ, Salvi SM. Optic nerve sheath fenestration via a supero-medial eyelid skin crease approach for the treatment of idiopathic intracranial hypertension in a UK population. Eye (London, England). 2021: 1418 [PMID: 32555545, https://doi.org/10.1038/s41433-020-1024-8]

21. Melson AT, Warmath JD, Moreau A, Farris BK. Superonasal Transconjunctival Optic Nerve Sheath Decompression: A Simplified Technique for Safe and Efficient Decompression. Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society. 2021: e16 [PMID: 32141981, https://doi.org/10.1097/WNO.0000000000000898]

22. Hagen SM, Wegener M, Toft PB, Fugleholm K, Jensen RH, Hamann S. Unilateral Optic Nerve Sheath Fenestration in Idiopathic Intracranial Hypertension: A 6-Month Follow-Up Study on Visual Outcome and Prognostic Markers. Life (Basel, Switzerland). 2021: [PMID: 34440522, https://doi.org/10.3390/life11080778]

23. Wadikhaye R, Alugolu R, Mudumba VS. A 270-Degree Decompression of Optic Nerve in Refractory Idiopathic Intracranial Hypertension Using an Ultrasonic Aspirator - A Prospective Institutional Study. Neurology India. 2021: 49 [PMID: 33642270, https://doi.org/10.4103/0028-3886.310080]

24. Obi EE, Lakhani BK, Burns J, Sampath R. Optic nerve sheath fenestration for idiopathic intracranial hypertension: a seven year review of visual outcomes in a tertiary centre. Clinical neurology and neurosurgery. 2015: 94 [PMID: 26164677, https://doi.org/10.1016/j.clineuro.2015.05.020]

25. Moreau A, Lao KC, Farris BK. Optic nerve sheath decompression: a surgical technique with minimal operative complications. Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society. 2014: 34 [PMID: 24275984, https://doi.org/10.1097/WNO.0000000000000065]

26. Pineles SL, Volpe NJ. Long-Term Results of Optic Nerve Sheath Fenestration for Idiopathic Intracranial Hypertension: Earlier Intervention Favours Improved Outcomes. Neuro-ophthalmology (Aeolus Press). 2013: 12 [PMID: 28163750, https://doi.org/10.3109/01658107.2012.757787]

27. Nithyanandam S, Manayath GJ, Battu RR. Optic nerve sheath decompression for visual loss in intracranial hypertension: report from a tertiary care center in South India. Indian journal of ophthalmology. 2008: 115 [PMID: 18292621, https://doi.org/10.4103/0301-4738.39115]

28. Knapp CM, Sampath R. Optic Nerve Sheath Fenestration: A Five Year Audit. Neuro-Ophthalmology. 2009: 173 https://doi.org/10.1080/01658100500481438]

29. Goh KY, Schatz NJ, Glaser JS. Optic nerve sheath fenestration for pseudotumor cerebri. Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society. 1997: 86 [PMID: 9176777, https://doi.org/10.1097/00041327-199706000-00003]

30. Acheson JF, Green WT, Sanders MD. Optic nerve sheath decompression for the treatment of visual failure in chronic raised intracranial pressure. Journal of neurology, neurosurgery, and psychiatry. 1994: 1426 [PMID: 7964827, https://doi.org/10.1136/jnnp.57.11.1426]

31. Kelman SE, Sergott RC, Cioffi GA, Savino PJ, Bosley TM, Elman MJ. Modified optic nerve decompression in patients with functioning lumboperitoneal shunts and progressive visual loss. Ophthalmology. 1991: 1449 [PMID: 1945323, https://doi.org/10.1016/s0161-6420(91)32113-4]

32. Spoor TC, Ramocki JM, Madion MP, Wilkinson MJ. Treatment of pseudotumor cerebri by primary and secondary optic nerve sheath decompression. Am J Ophthalmol. 1991: 177 [PMID: 1867302, https://doi.org/10.1016/s0002-9394(14)76698-x]

33. Herzau V. Fenestration of optic nerve sheaths in pseudotumor cerebri. Neuro-Ophthalmology. 2009: 65 https://doi.org/10.3109/01658108909019509]

34. Corbett JJ, Nerad JA, Tse DT, Anderson RL. Results of optic nerve sheath fenestration for pseudotumor cerebri. The lateral orbitotomy approach. Arch Ophthalmol. 1988: 1391 [PMID: 3273487, https://doi.org/10.1001/archopht.1988.01060140555022]

35. Brourman ND, Spoor TC, Ramocki JM. Optic nerve sheath decompression for pseudotumor cerebri. Arch Ophthalmol. 1988: 1378 [PMID: 3178548, https://doi.org/10.1001/archopht.1988.01060140542020]

36. Sergott RC, Savino PJ, Bosley TM. Modified optic nerve sheath decompression provides long-term visual improvement for pseudotumor cerebri. Arch Ophthalmol. 1988: 1384 [PMID: 3178549, https://doi.org/10.1001/archopht.1988.01060140548021]

37. Shaia JK, Sharma N, Kumar M, Chu J, Maatouk C, Talcott K, Singh R, Cohen DA. Changes in Prevalence of Idiopathic Intracranial Hypertension in the United States Between 2015 and 2022, Stratified by Sex, Race, and Ethnicity. Neurology. 2024: e208036 [PMID: 38181397, https://doi.org/10.1212/WNL.0000000000208036]

38. Fraz MA, Kim BM, Chen JJ, Lum F, Chen J, Liu GT, Hamedani AG, Consortium S. Nationwide Prevalence and Geographic Variation of Idiopathic Intracranial Hypertension among Women in the United States. Ophthalmology. 2025: 476 [PMID: 39510331, https://doi.org/10.1016/j.ophtha.2024.10.031]

39. Azzam AY, Nassar M, Morsy MM, Mohamed AA, Wu J, Essibayi MA, Altschul DJ. Epidemiological Patterns, Treatment Response, and Metabolic Correlations of Idiopathic Intracranial Hypertension: A US-Based Study From 1990 to 2024. medRxiv : the preprint server for health sciences. 2024: [PMID: 39711710, https://doi.org/10.1101/2024.12.08.24318685]

40. Friedman DI. Special Considerations in the Treatment of Idiopathic Intracranial Hypertension. Current neurology and neuroscience reports. 2024: 8 [PMID: 39656331, https://doi.org/10.1007/s11910-024-01398-z]

41. Biousse V, Newman NJ. Clinical trials for idiopathic intracranial hypertension: what are we treating? Nature reviews Neurology. 2024: 3 [PMID: 37923819, https://doi.org/10.1038/s41582-023-00892-1]

42. Friso S, Giacobbo V, Toscano LM, Baldo B, Guariento C, Lacarra F, Pin JN, Ancona C, Sartori S, Causin F, Toldo I. A systematic review of surgical and interventional radiology procedures for pediatric idiopathic intracranial hypertension. Frontiers in pediatrics. 2024: 1466688 [PMID: 39539766, https://doi.org/10.3389/fped.2024.1466688]

43. Corecha Santos R, Gupta B, Santiago RB, Sabahi M, Kaye B, Dabecco R, Obrzut M, Adada B, Velasquez N, Borghei-Razavi H. Endoscopic endonasal optic nerve sheath decompression (EONSD) for idiopathic intracranial hypertension: Technical details and meta-analysis. Clinical neurology and neurosurgery. 2023: 107750 [PMID: 37146367, https://doi.org/10.1016/j.clineuro.2023.107750]

44. Prokop K, Opechowska A, Sieskiewicz A, Lisowski L, Mariak Z, Lyson T. Effectiveness of optic nerve sheath fenestration in preserving vision in idiopathic intracranial hypertension: an updated meta-analysis and systematic review. Acta neurochirurgica. 2024: 476 [PMID: 39585430, https://doi.org/10.1007/s00701-024-06345-y]

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright (c) 2025 ASIDE Internal Medicine